Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Houston, TX
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Houston, TX
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Humble, TX
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Humble, TX
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Lampasas, TX
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Lampasas, TX
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
McKinney, TX
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
McKinney, TX
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Missouri City, TX
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Missouri City, TX
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Plano, TX
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Plano, TX
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Port Arthur, TX
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Port Arthur, TX
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
San Antonio, TX
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Sugar Land, TX
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Orem, UT
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Orem, UT
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
West Valley City, UT
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
West Valley City, UT
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Chesapeake, VA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Fairfax, VA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Fairfax, VA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Norfolk, VA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Richmond, VA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Spokane, WA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Vancouver, WA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Vancouver, WA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Kingwood, WV
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Kingwood, WV
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
La Crosse, WI
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
La Crosse, WI
Click here to add this to my saved trials
Proof of Concept: "Bottom's Up" Seat to Treat Constipation
Proof of Concept: A Commode Assist Device for Excessive Perineal Descent
Status: Enrolling
Updated:  10/18/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Proof of Concept: "Bottom's Up" Seat to Treat Constipation
Proof of Concept: A Commode Assist Device for Excessive Perineal Descent
Status: Enrolling
Updated: 10/18/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
Borland-Groover Clinic
mi
from
Jacksonville, FL
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
Borland-Groover Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
Augusta University
mi
from
Augusta, GA
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
MGG Group, Co. Inc./Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
MGG Group, Co. Inc./Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
Mgh Boston
mi
from
Boston, MA
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
Mgh Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
University of Michigan Hospital
mi
from
Ann Arbor, MI
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
University of Michigan Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
Temple University School of Medicine
mi
from
Philadelphia, PA
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
Temple University School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
CTRS LLC
mi
from
Pittsburgh, PA
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
CTRS LLC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
Bat-Yamon
mi
from
Bat Yam,
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
Bat-Yamon
mi
from
Bat Yam,
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
NYU Langone Medical Center
mi
from
New York, NY
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated:  11/5/2017
Huoston Methodist Hosptial
mi
from
Houston, TX
Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals
Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.
Status: Enrolling
Updated: 11/5/2017
Huoston Methodist Hosptial
mi
from
Houston, TX
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
University of South Alabama Women's and Children's Hospital
mi
from
Mobile, AL
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
University of South Alabama Women's and Children's Hospital
mi
from
Mobile, AL
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Arizona Children's Center at Maricopa Medical Center
mi
from
Phoenix, AZ
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Arizona Children's Center at Maricopa Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Northwest Arkansas Pediatric Clinic
mi
from
Fayetteville, AR
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Northwest Arkansas Pediatric Clinic
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
WCCT Global, LLC
mi
from
Costa Mesa, CA
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
WCCT Global, LLC
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Loma Linda University Health Care
mi
from
Loma Linda, CA
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Loma Linda University Health Care
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
University of California at San Francisco
mi
from
San Francisco, CA
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
MCB Clinical Research
mi
from
Colorado Springs, CO
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
MCB Clinical Research
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Nemours/Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Nemours/Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Emmerson Clinical Research
mi
from
Washington,
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Emmerson Clinical Research
mi
from
Washington,
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Palmetto Professional Research
mi
from
Hialeah, FL
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Palmetto Professional Research
mi
from
Hialeah, FL
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Savin Medical Group Research Center
mi
from
Miami Lakes, FL
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Savin Medical Group Research Center
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Acevedo Clinical Research Associates
mi
from
Miami, FL
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Acevedo Clinical Research Associates
mi
from
Miami, FL
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Nemour's Children's Clinic
mi
from
Pensacola, FL
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Nemour's Children's Clinic
mi
from
Pensacola, FL
Click here to add this to my saved trials
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated:  11/28/2017
Children's Center for Digestive Health Care/GI Care for Kids
mi
from
Atlanta, GA
Long-term Safety and Efficacy of Lubiprostone in Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
Status: Enrolling
Updated: 11/28/2017
Children's Center for Digestive Health Care/GI Care for Kids
mi
from
Atlanta, GA
Click here to add this to my saved trials